Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine quantification in Bellovac autologous retransfusion after total knee replacement
NL-OMON33633Active, not recruiting
- Sponsor
- Haaglanden Medical Centre
- Start
- Mar 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ropivacaine in osteoarthritis (OA), sponsored by Haaglanden Medical Centre. Primary endpoints: Cumulative ropivacaine level at time of planned retransfusion and Serum ropivacaine concentrations. Started Mar 2009; status: active, not recruiting.
02
Drugs
ropivacaine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NL-OMON33633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33633.